GB9419253D0 - Screen - Google Patents
ScreenInfo
- Publication number
- GB9419253D0 GB9419253D0 GB9419253A GB9419253A GB9419253D0 GB 9419253 D0 GB9419253 D0 GB 9419253D0 GB 9419253 A GB9419253 A GB 9419253A GB 9419253 A GB9419253 A GB 9419253A GB 9419253 D0 GB9419253 D0 GB 9419253D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- screen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/06—Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13011193A | 1993-09-30 | 1993-09-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
GB9419253D0 true GB9419253D0 (en) | 1994-11-09 |
GB2282378A GB2282378A (en) | 1995-04-05 |
Family
ID=22443102
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9419253A Withdrawn GB2282378A (en) | 1993-09-30 | 1994-09-23 | Conjugates of epitopes of HIV with a protein complex from Neisseria |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2282378A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2237065C2 (en) * | 2002-10-03 | 2004-09-27 | Государственный научный центр вирусологии и биотехнологии "Вектор" | Chimeric peptide immunogenic library mimicking genetic diversity of hypervariable region of protein v3 of human immunodeficiency virus envelope gp120 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL94558A0 (en) * | 1989-06-06 | 1991-03-10 | Merck & Co Inc | Conjugate immunogen for aids and vaccine and pharmaceutical compositions containing it |
CA2047073A1 (en) * | 1990-07-19 | 1992-01-20 | William J. Leanza | Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties |
EP0467714A1 (en) * | 1990-07-19 | 1992-01-22 | Merck & Co. Inc. | The class II protein of the outer membrane of neisseria meningitidis |
CA2047031A1 (en) * | 1990-07-19 | 1992-01-20 | Stephen Marburg | Peptide-polysaccharide-protein conjugate vaccines |
IL99077A0 (en) * | 1990-08-13 | 1992-07-15 | Merck & Co Inc | New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them |
EP0519554A1 (en) * | 1991-06-19 | 1992-12-23 | Merck & Co. Inc. | Conjugates of the class II protein of the outer membrane of neisseria meningitidis and of HIV-1 related peptides |
WO1993003766A1 (en) * | 1991-08-13 | 1993-03-04 | Repligen Corporation | Multiple antigen peptides for use as hiv vaccines |
WO1994002626A1 (en) * | 1992-07-20 | 1994-02-03 | Merck & Co., Inc. | Immunological conjugates of ompc and hiv-specific selected principal neutralization epitopes |
GB2271995A (en) * | 1992-10-15 | 1994-05-04 | Merck & Co Inc | HIV peptide conjugated via anionic spacer to protein |
-
1994
- 1994-09-23 GB GB9419253A patent/GB2282378A/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
GB2282378A (en) | 1995-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2279003B (en) | Display arrangement | |
DE59407177D1 (en) | 2-fluorcycloyhexen-derivate | |
GB2297785B (en) | Screen | |
GB9206547D0 (en) | Screen arrangement | |
GB9112683D0 (en) | Screen | |
AU122479S (en) | Label-printer | |
GB2284226B (en) | Screen | |
GB9419253D0 (en) | Screen | |
GB9321395D0 (en) | Improved stifting screen | |
DE59403125D1 (en) | Hohlleitermultiplexer/-demultiplexer | |
GB9308637D0 (en) | Screen printing | |
CA73639S (en) | Handstamp | |
CA72257S (en) | Floorstand | |
ZA954574B (en) | Screen | |
GB9502042D0 (en) | Screen | |
GB9402008D0 (en) | Screen | |
GB9308787D0 (en) | Vibratory screen | |
GB9314655D0 (en) | Shower screen | |
GB9303750D0 (en) | Framework | |
ZA949527B (en) | Framework | |
AU122386S (en) | Panel | |
AU122378S (en) | Panel | |
AU122384S (en) | Panel | |
GB9309852D0 (en) | Panel | |
GB9301313D0 (en) | Panel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |